Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Marston Linehan. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43–49. doi:10.1038/nature12222
   PubMedGoogle Scholar
• Linehan WM, Schmidt LS, Crooks DR, et al. The metabolic basis of kidney cancer. Cancer Discov. 2019;9(8):1006–1021. doi:10.1158/2159-8290.CD-18-1354
   PubMed Web of Science ®Google Scholar
• DiNatale RG, Sanchez A, Hakimi AA, et al. Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinoma. Urol Oncol. 2020;38(10):755–762. doi:10.1016/j.urolonc.2019.04.028
   PubMed Web of Science ®Google Scholar
• Jin T, Wang C, Tian Y, et al. Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel. Cancer Lett. 2020;470:181–190. doi:10.1016/j.canlet.2019.11.022
   PubMed Web of Science ®Google Scholar
• Yoshida GJ. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res. 2015;34:111. doi:10.1186/s13046-015-0221-y
   PubMed Web of Science ®Google Scholar
• Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell. 2016;61(5):667–676. doi:10.1016/j.molcel.2016.02.011
   PubMed Web of Science ®Google Scholar
• Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20(7):745–754. doi:10.1038/s41556-018-0124-1
   PubMed Web of Science ®Google Scholar
• Keckesova Z, Donaher JL, Cock D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543(7647):681–686. doi:10.1038/nature21408
   PubMed Web of Science ®Google Scholar
• Yang Y, Karakhanova S, Hartwig W, et al. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. J Cell Physiol. 2016;231(12):2570–2581. doi:10.1002/jcp.25349
   PubMed Web of Science ®Google Scholar
• Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel? Nat Rev Cancer. 2014;14(11):709–721. doi:10.1038/nrc3803
   PubMed Web of Science ®Google Scholar
• Poprac P, Jomova K, Simunkova M, et al. Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci. 2017;38(7):592–607. doi:10.1016/j.tips.2017.04.005
   PubMed Web of Science ®Google Scholar
• Luchetti F, Canonico B, Betti M, et al. Melatonin signaling and cell protection function. Faseb J. 2010;24(10):3603–3624. doi:10.1096/fj.10-154450
   PubMed Web of Science ®Google Scholar
• Venegas C, García JA, Escames G, et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res. 2012;52(2):217–227. doi:10.1111/j.1600-079X.2011.00931.x
   PubMed Web of Science ®Google Scholar
• Audet-Walsh É, Papadopoli DJ, Gravel SP, et al. The PGC-1α/ERRα axis represses One-carbon metabolism and promotes sensitivity to anti-folate therapy in breast cancer. Cell Rep. 2016;14(4):920–931. doi:10.1016/j.celrep.2015.12.086
   PubMed Web of Science ®Google Scholar
• Chen X, Hao B, Li D, et al. Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3/PDH axis. J Pineal Res. 2021;71(2):e12755. doi:10.1111/jpi.12755
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Sharma R, Ma Q, et al. Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis. Cell Mol Life Sci. 2020;77(13):2527–2542. doi:10.1007/s00018-019-03438-1
   PubMed Web of Science ®Google Scholar
• Talib WH. Melatonin and cancer hallmarks. Molecules. 2018;23(3). doi:10.3390/molecules23030518
   Web of Science ®Google Scholar
• Chao CC, Chen PC, Chiou PC, et al. Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to twist. Clin Sci (Lond). 2019;133(5):709–722. doi:10.1042/CS20180945
   PubMed Web of Science ®Google Scholar
• Shen YQ, Guerra-Librero A, Fernandez-Gil BI, et al. Combination of melatonin and rapamycin for head and neck cancer therapy: suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. J Pineal Res. 2018;64(3):e12461.
   Web of Science ®Google Scholar
• Ma Z, Yang Y, Fan C, et al. Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis. Oncotarget. 2016;7(29):45513–45524. doi:10.18632/oncotarget.9995
   PubMedGoogle Scholar
• Chakraborty S, Balan M, Sabarwal A, et al. Metabolic reprogramming in renal cancer: events of a metabolic disease. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188559. doi:10.1016/j.bbcan.2021.188559
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Penkov K, Haanen J, et al. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380(12):1103–1115. doi:10.1056/NEJMoa1816047
   PubMed Web of Science ®Google Scholar
• Albiges L, Tannir NM, Burotto M, et al. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial. ESMO Open. 2020;5(6):e001079. doi:10.1136/esmoopen-2020-001079
   PubMed Web of Science ®Google Scholar
• Randrup Hansen C, Grimm D, Bauer J, et al. Effects and side effects of using sorafenib and sunitinib in the treatment of metastatic renal cell carcinoma. Int J Mol Sci. 2017;18(2). doi:10.3390/ijms18020461
   PubMed Web of Science ®Google Scholar
• Zhang MX, Wang JL, Mo CQ, et al. CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1. Oncogene. 2022;41(33):3979–3990. doi:10.1038/s41388-022-02386-8
   PubMed Web of Science ®Google Scholar
• Xiao C, Zhang W, Hua M, et al. RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop. Cell Mol Biol Lett. 2022;27(1):36. doi:10.1186/s11658-022-00337-5
   PubMed Web of Science ®Google Scholar
• Feng J, Chen X, Liu R, et al. Melatonin protects against myocardial ischemia-reperfusion injury by elevating Sirtuin3 expression and manganese superoxide dismutase activity. Free Radic Res. 2018;52(8):840–849. doi:10.1080/10715762.2018.1461215
   PubMed Web of Science ®Google Scholar
• Bilska B, Schedel F, Piotrowska A, et al. Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells. J Pineal Res. 2021;70(3):e12728. doi:10.1111/jpi.12728
   PubMed Web of Science ®Google Scholar
• García JJ, López-Pingarrón L, Almeida-Souza P, et al. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res. 2014;56(3):225–237. doi:10.1111/jpi.12128
   PubMed Web of Science ®Google Scholar
• Halpern B, Mancini MC, Bueno C, et al. Melatonin increases brown adipose tissue volume and activity in patients with melatonin deficiency: a proof-of-concept study. Diabetes. 2019;68(5):947–952. doi:10.2337/db18-0956
   PubMed Web of Science ®Google Scholar
• Herst PM, Grasso C, Berridge MV. Metabolic reprogramming of mitochondrial respiration in metastatic cancer. Cancer Metastasis Rev. 2018;37(4):643–653. doi:10.1007/s10555-018-9769-2
   PubMed Web of Science ®Google Scholar
• Meng F, Wu L, Dong L, et al. EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming. Nat Commun. 2019;10(1):5033. doi:10.1038/s41467-019-13034-3
   PubMedGoogle Scholar
• Gerresheim GK, Roeb E, Michel AM, et al. Hepatitis C virus downregulates core subunits of oxidative phosphorylation, reminiscent of the Warburg effect in cancer cells. Cells. 2019;8(11). doi:10.3390/cells8111410
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Sharma R, Ma Q. Switching diseased cells from cytosolic aerobic glycolysis to mitochondrial oxidative phosphorylation: a metabolic rhythm regulated by melatonin? J Pineal Res. 2021;70(1):e12677. doi:10.1111/jpi.12677
   PubMed Web of Science ®Google Scholar
• Akram M. Mini-review on glycolysis and cancer. J Cancer Educ. 2013;28(3):454–457. doi:10.1007/s13187-013-0486-9
   PubMed Web of Science ®Google Scholar
• Zhao X, Bai Z, Wu P, et al. S100p enhances the chemosensitivity of human gastric cancer cell lines. Cancer Biomark. 2013;13(1):1–10. doi:10.3233/CBM-130330
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu J, Peng M, et al. BMP4 is involved in the chemoresistance of myeloid leukemia cells through regulating autophagy-apoptosis balance. Cancer Invest. 2013;31(8):555–562. doi:10.3109/07357907.2013.834925
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Mayo JC, Tan DX, et al. Melatonin as an antioxidant: under promises but over delivers. J Pineal Res. 2016;61(3):253–278. doi:10.1111/jpi.12360
   PubMed Web of Science ®Google Scholar
• Cruz-Gregorio A, Aranda-Rivera AK, Pedraza-Chaverri J, et al. Redox-sensitive signaling pathways in renal cell carcinoma. Biofactors. 2022;48(2):342–358. doi:10.1002/biof.1784
   PubMed Web of Science ®Google Scholar
• Cadenas E. Basic mechanisms of antioxidant activity. Biofactors. 1997;6(4):391–397. doi:10.1002/biof.5520060404
   PubMed Web of Science ®Google Scholar
• Kryston TB, Georgiev AB, Pissis P, et al. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res. 2011;711(1-2):193–201. doi:10.1016/j.mrfmmm.2010.12.016
   PubMed Web of Science ®Google Scholar
• Cruz-Gregorio A, Manzo-Merino J, Lizano M. Cellular redox, cancer and human papillomavirus. Virus Res. 2018;246:35–45. doi:10.1016/j.virusres.2018.01.003
   PubMed Web of Science ®Google Scholar
• Leja-Szpak A, Jaworek J, Pierzchalski P, et al. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res. 2010;49(3):248–255. doi:10.1111/j.1600-079X.2010.00789.x
   PubMed Web of Science ®Google Scholar
• Bejarano I, Redondo PC, Espino J, et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res. 2009;46(4):392–400. doi:10.1111/j.1600-079X.2009.00675.x
   PubMed Web of Science ®Google Scholar
• Casado-Zapico S, Martín V, García-Santos G, et al. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients. J Pineal Res. 2011;50(3):345–355. doi:10.1111/j.1600-079X.2010.00850.x
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Y, Musa AE. Regulation of cell death mechanisms by melatonin: implications in cancer therapy. Anticancer Agents Med Chem. 2022;22(11):2080–2090. doi:10.2174/1871520621999211108090712
   PubMed Web of Science ®Google Scholar
• Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18(16):1926–1945. doi:10.1101/gad.1212704
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12(1):9–22. doi:10.1016/j.ccr.2007.05.008
   PubMed Web of Science ®Google Scholar
• Manning BD. Balancing Akt with S6K. J Cell Biol. 2004;167(3):399–403. doi:10.1083/jcb.200408161
   PubMed Web of Science ®Google Scholar
• Xu F, Na L, Li Y, et al. RETRACTED ARTICLE: roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci. 2020;10(1):54. doi:10.1186/s13578-020-00416-0
   PubMed Web of Science ®Google Scholar
• Yang Y, Li S, Wang Y, et al. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. Signal Transduct Target Ther. 2022;7(1):329. doi:10.1038/s41392-022-01168-8
   PubMed Web of Science ®Google Scholar
• Seely D, Wu P, Fritz H, et al. Melatonin as adjuvant cancer care With and without chemotherapy. Integr Cancer Ther. 2012;11(4):293–303. doi:10.1177/1534735411425484
   PubMed Web of Science ®Google Scholar